KIFC1 and cancer: However, their pharmacological specificity for cancer over normal cells remains limited (Patel et al, 2018; Wu et al, 2013; Yukawa et al, 2018) and next-generation KIFC1 inhibitors or novel ways to target centrosome-clustering are needed.